We are live on ! Find out more
AZN icon

AstraZeneca
AZN

1,229 hedge funds and large institutions have $39.1B invested in AstraZeneca in 2024 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 496 increasing their positions, 396 reducing their positions, and 89 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $485M | Put options by funds: $334M

31% more first-time investments, than exits

New positions opened: 117 | Existing positions closed: 89

25% more repeat investments, than reductions

Existing positions increased: 496 | Existing positions reduced: 396

1% more funds holding

Funds holding: 1,211 → 1,229 (+18)

0% more capital invested

Capital invested by funds: $39B → $39.1B (+$45.6M)

0.03% more ownership

Funds ownership: 16.11% → 16.15% (+0.03%)

11% less funds holding in top 10

Funds holding in top 10: 19 → 17 (-2)

Holders
1,229
Holders Change
+18
Holders Change %
+1.49%
% of All Funds
17.65%
Holding in Top 10
17
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-10.53%
% of All Funds
0.24%
New
117
Increased
496
Reduced
396
Closed
89
Calls
$485M
Puts
$334M
Net Calls
+$152M
Net Calls Change
-$13M

Top Buyers

1
Bank of America
Bank of America
North Carolina
+$808M
2
GQG Partners
GQG Partners
Florida
+$200M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$130M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$126M
5
Franklin Resources
Franklin Resources
California
+$123M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$268M
2
Holocene Advisors
Holocene Advisors
New York
-$197M
3
FCM
Farallon Capital Management
California
-$188M
4
Jennison Associates
Jennison Associates
New York
-$166M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$165M
Name Holding Trade Value Shares
Change 		Change in
Stake
PFPT
851
Pinnacle Financial Partners (Tennessee)
Tennessee
$304K +$76.8K +476 +32%
APWM
852
Argonautica Private Wealth Management
Massachusetts
$303K +$1.61K +10 +0.5%
KCM
853
Kendall Capital Management
Maryland
$303K -$2.1K -13 -0.7%
CPIA
854
Cornell Pochily Investment Advisors
New York
$300K – – –
FLII
855
First Long Island Investors
New York
$299K – – –
WPW
856
Waldron Private Wealth
Pennsylvania
$299K +$25.3K +157 +9%
VC
857
Veracity Capital
Georgia
$299K +$13.2K +82 +4%
SFG
858
SevenBridge Financial Group
Pennsylvania
$297K +$26.3K +163 +8%
MNBTD
859
Moody National Bank Trust Division
Texas
$296K +$307K +1,899 New
PGAM
860
Princeton Global Asset Management
New Jersey
$295K -$12.4K -77 -4%
LCGC
861
Legacy Capital Group California
California
$294K +$304K +1,885 New
WAM
862
Wolverine Asset Management
Illinois
$292K – – –
FVWA
863
Foster Victor Wealth Advisors
South Carolina
$291K +$35.4K +219 +13%
CCM
864
Canal Capital Management
Virginia
$290K +$10.2K +63 +4%
GHAM
865
Gilman Hill Asset Management
Connecticut
$289K +$90.9K +563 +44%
WPW
866
Warther Private Wealth
Ohio
$288K -$40.4K -250 -12%
PTC
867
Philadelphia Trust Company
Pennsylvania
$287K -$17.1K -106 -5%
NQWM
868
Northwest Quadrant Wealth Management
Oregon
$287K +$646 +4 +0.2%
WP
869
WMS Partners
Maryland
$287K +$39.7K +246 +15%
Empower Advisory Group
870
Empower Advisory Group
Colorado
$285K -$344K -2,130 -54%
PPC
871
Park Place Capital
Alabama
$284K – – –
ABWM
872
Alpine Bank Wealth Management
Colorado
$282K +$292K +1,810 New
WFS
873
Widmann Financial Services
Maryland
$281K +$32.3K +200 +12%
WC
874
Wexford Capital
Florida
$281K -$634K -3,929 -69%
HI
875
Hudock Inc
Pennsylvania
$281K – – –
33 34
35
36 37

AZN Hedge Fund Activity: Q3 2024 in Review

1,229 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q3 2024, worth a combined $39.1B — up 0.12% from $39B a quarter earlier.

Buyers outnumbered sellers: 117 funds opened new AZN positions and 89 closed out — a net gain of 28 holders — while 496 added to existing stakes and 396 trimmed.

The largest buyer was Bank of America, adding an estimated $808M. The largest seller was Wellington Management Group, cutting an estimated $268M.

  • 1,229 institutional investors held AstraZeneca (AZN) as of Q3 2024, up from 1,211 in Q2 2024.
  • Funds reported $39.1B of AstraZeneca stock for Q3 2024, up 0.12% quarter-over-quarter.
  • 117 funds opened new AstraZeneca positions in Q3 2024 and 89 closed out, a net change of +28 holders.
  • The largest AstraZeneca buyer in Q3 2024 was Bank of America, an estimated $808M added.
  • The largest AstraZeneca seller in Q3 2024 was Wellington Management Group, an estimated $268M sold.

Based on aggregated 13F filings for Q3 2024.